These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 21806565

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia.
    Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, Daley J.
    Clin Infect Dis; 2006 Apr 15; 42(8):1093-101. PubMed ID: 16575726
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prior pneumococcal and influenza vaccinations and in-hospital outcomes for community-acquired pneumonia in elderly veterans.
    Li C, Gubbins PO, Chen GJ.
    J Hosp Med; 2015 May 15; 10(5):287-93. PubMed ID: 25676363
    [Abstract] [Full Text] [Related]

  • 8. Impact of the pneumococcal vaccine on long-term morbidity and mortality of adults at high risk for pneumonia.
    Johnstone J, Eurich DT, Minhas JK, Marrie TJ, Majumdar SR.
    Clin Infect Dis; 2010 Jul 01; 51(1):15-22. PubMed ID: 20504233
    [Abstract] [Full Text] [Related]

  • 9. Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience.
    Baldo V, Cocchio S, Gallo T, Furlan P, Romor P, Bertoncello C, Buja A, Baldovin T.
    PLoS One; 2016 Jul 01; 11(11):e0166637. PubMed ID: 27846277
    [Abstract] [Full Text] [Related]

  • 10. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis.
    Hedlund J.
    Scand J Infect Dis Suppl; 1995 Jul 01; 97():1-60. PubMed ID: 8584866
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prevention of community-acquired pneumonia among a cohort of hospitalized elderly: benefit due to influenza and pneumococcal vaccination not demonstrated.
    Skull SA, Andrews RM, Byrnes GB, Kelly HA, Nolan TM, Brown GV, Campbell DA.
    Vaccine; 2007 Jun 06; 25(23):4631-40. PubMed ID: 17478015
    [Abstract] [Full Text] [Related]

  • 13. Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
    Vila-Córcoles A, Ochoa-Gondar O, Hospital I, Ansa X, Vilanova A, Rodríguez T, Llor C, EVAN Study Group.
    Clin Infect Dis; 2006 Oct 01; 43(7):860-8. PubMed ID: 16941367
    [Abstract] [Full Text] [Related]

  • 14. Severity scoring in community-acquired pneumonia caused by Streptococcus pneumoniae: a 5-year experience.
    Ioachimescu OC, Ioachimescu AG, Iannini PB.
    Int J Antimicrob Agents; 2004 Nov 01; 24(5):485-90. PubMed ID: 15519482
    [Abstract] [Full Text] [Related]

  • 15. Influenza vaccination and risk of mortality among adults hospitalized with community-acquired pneumonia.
    Spaude KA, Abrutyn E, Kirchner C, Kim A, Daley J, Fisman DN.
    Arch Intern Med; 2007 Jan 08; 167(1):53-9. PubMed ID: 17210878
    [Abstract] [Full Text] [Related]

  • 16. Prevention of mortality and pneumonia among nursing home older adults by dual pneumococcal and seasonal influenza vaccination during a pandemic caused by novel pandemic influenza A (H1N1).
    Chan TC, Hung IF, Luk JK, Shea YF, Chan FH, Woo PC, Chu LW.
    J Am Med Dir Assoc; 2012 Oct 08; 13(8):698-703. PubMed ID: 22722051
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study.
    Ochoa-Gondar O, Vila-Corcoles A, Ansa X, Rodriguez-Blanco T, Salsench E, de Diego C, Raga X, Gomez F, Valdivieso E, Fuentes C, Palacios L, EVAN Study Group.
    Vaccine; 2008 Apr 07; 26(16):1955-62. PubMed ID: 18343541
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against community-acquired pneumonia in the general population aged ≥ 60 years: 3 years of follow-up in the CAPAMIS study.
    Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, Hospital-Guardiola I.
    Clin Infect Dis; 2014 Apr 07; 58(7):909-17. PubMed ID: 24532544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.